Action Potential Venture Capital
Status
ACTIVE
Global HQ
United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
Industries
- Pharmaceuticals
- Biotech
- Health Tech
About
Action Potential Venture Capital (APVC) is a leading medical Technology venture Capital firm founded by GSK in 2013. APVC invests globally and takes a handson role on the boards of startups advancing bioelectronic medicines and their enabling technologies. The firm is committed to fostering an inclusive and diverse workspace, contributing to a more equitable healthcare investor and entrepreneurial Community. APVC's investment team expressly extends this commitment to the companies They invest in. APVC backs teams developing innovative medical and health tech solutions, focusing on transformative therapies and technologies aimed at improving patient outcomes.
Action Potential Venture Capital (APVC) is a leading medical Technology venture Capital firm founded by GSK in 2013. APVC invests globally and takes a handson role on the boards of startups advancing bioelectronic medicines and their enabling technologies. The firm is committed to fostering an inclusive and diverse workspace, contributing to a more equitable healthcare investor and entrepreneurial Community. APVC's investment team expressly extends this commitment to the companies They invest in. APVC backs teams developing innovative medical and health tech solutions, focusing on transformative therapies and technologies aimed at improving patient outcomes.
Investment Thesis
APVC is dedicated to bringing bioelectronic medicines to patients by supporting innovators and entrepreneurs pioneering a bioelectronic future.
Action Potential Venture Capital Contacts Information
Primary contact
Portfolio
Look Cycle
Biobest
Medipress
Questel
Explore Media Group